ARC Linkage - $340,000

Drug molecules are being developed for respiratory diseases, which are highly potent but beyond our capability in terms of delivery. Using a combination of high-end particle engineering and characterisation approaches, coupled with computational modeling, we will develop a theoretical model that can be used to delivery ultra-low doses to the lung.